Purpura fulminans on invasive meningococcal disease

Authors

  • Igor Gutschov Oviedo Garcia Instituto de Infectologia Emílio Ribas, Infectologia - São Paulo - São Paulo - Brasil
  • Giselle Burlamaqui Klautau Instituto de Infectologia Emílio Ribas, Infectologia - São Paulo - São Paulo - Brasil

DOI:

https://doi.org/10.5935/2764-734X.e202201006

Keywords:

Meningococcal Infections, Neisseria meningitidis, Serogroup W-135, Purpura Fulminans

Abstract

Meningococcal disease has been responsible for millions of deaths in its epidemics worldwide. This report aims to highlight the rapid evolution of this currently less prevalent disease and its main complication, purpura fulminans, a rare and highly lethal syndrome, as well as to comment on its clinical and surgical management. This is a 23-year-old female healthcare professional who was diagnosed with meningoccemia caused by serogroup-W N. meningitidis, clinically progressing with purpura fulminans and subsequent need for amputation of the affected segments, in addition to other complications. The patient was not vaccinated for this serogroup, which would have avoided this serious condition - vaccination should be considered for the risk group to which she belonged. It’s an important case report in order to not forget diseases that are allegedly under control, but decades or centuries ago generated major health problems.

References

1. Focaccia R. Doença meningocócica. In: Veronesi R, Focaccia R, eds. Tratado de infectologia. 5ª ed. São Paulo: Atheneu; 2015. p. 1053-66.

2. Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Situação epidemiológica da doença meningocócica, Brasil, 2007-2013. Boletim epidemiológico - volume 47, nº 29, 2016 [Internet]. Brasília (DF): Ministério da Saúde; 2020; [acesso em 2020 Dez 20]. Disponível em: https://www.gov.br/saude/pt-br/assuntos/boletins-epidemiologicos/numeros-anteriores

3. Ministério da Saúde (BR). Meningite [Internet]. Brasília (DF): Ministério da Saúde; 2020; [acesso em 2020 Dez 20]. Disponível em: https://www.gov.br/saude/pt-br/assuntos/saude-de-a-a-z/m/meningite

4. Guiddir T, Gros M, Hong E, Terrade A, Denizon M, Deghmane AE, et al. Unusual initial abdominal presentations of invasive meningococcal disease. Clin Infect Dis. 2018 Oct;67(8):1220-7. DOI: https://doi.org/10.1093/cid/ciy257

5. Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021. Crit Care Med. 2021 Nov;49(11):e1063-e43. DOI: https://doi.org/10.1097/CCM.0000000000005337

6. Abe R, Oda S, Sadahiro T, Nakamura M, Hirayama Y, Tateishi Y, et al. Gram-negative bacteremia induces greater magnitude of inflammatory response than Gram-positive bacteremia. Crit Care. 2010 Mar;14(2):R27. DOI: https://doi.org/10.1186/cc8898

7. Chalmers E, Cooper P, Forman K, Grimley C, Khair K, Minford A, et al. Purpura fulminans: recognition, diagnosis and management. Arch Dis Child. 2011;96(11):1066-71. DOI: https://doi.org/10.1136/adc.2010.199919

8. Colling ME, Bendapudi PK. Purpura fulminans: mechanism and management of dysregulated hemostasis. Transfus Med Rev. 2018 Apr;32(2):69-76. DOI: https://doi.org/10.1016/j.tmrv.2017.10.001

9. Ministério da Saúde (BR). Secretaria de Vigilância em Saúde. Departamento de Imunização e Doenças Transmissíveis. Coordenação-Geral do Programa Nacional de Imunizações. Manual dos centros de referência para imunobiológicos especiais [Internet]. 5ª ed. Brasília (DF): Ministério da Saúde; 2019; [acesso em 2020 Dez 20]. Disponível em: https://pesquisa.bvsalud.org/bvsms/resource/pt/mis-40552

Downloads

Published

2022-06-15

How to Cite

Garcia, I. G. O., & Klautau, G. B. (2022). Purpura fulminans on invasive meningococcal disease. Infections in Evidence, 1, e202201006. https://doi.org/10.5935/2764-734X.e202201006

Issue

Vol. 1 (2022)

Section

Case Reports

License

Copyright (c) 2022 Infections in Evidence

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

The Copyright Transfer Agreement assumes that the authors are the legitimate holders of the copyright of the Case Report in question, without infringing any copyright, trademark or patent of others. In this way, they transfer all rights to this manuscript or any revision, version or translation of it to the Journal, including here the exclusivity of its eventual commercialization, provided that in accordance with ethical and moral precepts and relevant Brazilian legislation. All articles in the INFECTIONS IN EVIDENCE Journal are published under the terms of international license 4.0 of the Creative Commons Attribution, which allows users to freely read, download, share and adapt cultural and scientific productions, provided that due credit is given to the original authors and publication.
The Copyright Transfer Agreement also understands that the authors guarantee that the respective Case Report has never been published in another communication vehicle or scientific journal. Papers presented at meetings and/or scientific congresses may be published in the electronic journal INFECTIOUS DISEASES IN EVIDENCE - Case Reports, provided that they have not been published in whole or in part in their Proceedings or Annals.